Sudarshan Pharma Industries Limited (SPIL), incorporated in 2008 and headquartered in Mumbai, operates as a contract manufacturing facility, sourcing and supplying generic formulations. The company’s activities also encompass import and export operations, as well as the supply of specialty chemicals, Active Pharmaceutical Ingredients (APIs), and Intermediates. To meet clients’ specific requirements, SPIL outsources the manufacturing facility from suppliers in India and abroad.
The wide range of generic products supplied by SPIL finds applications in diverse industries, including paint, food, pharma, and adhesives. Moreover, the company engages in contract manufacturing, supplying, and outsourcing of medicines and pharmaceutical formulations to hospitals, NGOs, government agencies, and healthcare institutes. With a portfolio of 50 pharma formulations, SPIL offers branded products in various forms such as tablets, ointments, capsules, and injectables.
To strengthen its market presence, SPIL operates its own sales force and distribution network across five states for ethical marketing of pharmaceutical formulations and branded products in both Indian and international markets. Additionally, the company provides formulation development and Quality Control (QC) services, delivering customized solutions to meet unique client needs.
The competitive strengths of Sudarshan Pharma Industries Limited include its customer-centric and order-driven business model, an extensive range of product offerings, strategic contract manufacturing arrangements, a robust distribution, marketing, and sales network, and a diversified portfolio of business operations.
With its dedication to customer satisfaction and a versatile business approach, SPIL continues to thrive in the pharmaceutical and specialty chemicals industries, delivering innovative solutions and value to its clients.
Sudarshan Pharma Industries Ltd Stock Quote #
- Open: ₹65.98
- High – Low: ₹65.98 – ₹64.00
- Previous Close: ₹62.55
- Total Traded Value: 9,600
- 52 Weeks High: ₹74.80 (Apr 21, 2023)
- 52 Weeks Low: ₹51.85 (Mar 31, 2023)
- Updated On: Jul 24, 2023 4:00 PM
Sudarshan Pharma Industries IPO Details #
| IPO Date | Mar 9, 2023 to Mar 14, 2023 |
| Listing Date | Mar 22, 2023 |
| Face Value | ₹10 per share |
| Price | ₹71 to ₹73 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 6,862,400 shares (aggregating up to ₹50.10 Cr) |
| Fresh Issue | 6,862,400 shares (aggregating up to ₹50.10 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
| Market Maker portion | 344,000 shares Gretex Share Broking |
Sudarshan Pharma Industries IPO Reservation #
| Anchor Investor Shares Offered | 780,800 (10.83%) |
| Market Maker Shares Offered | 344,000 (4.77%) |
| QIB Shares Offered | 521,600 (7.24%) |
| NII (HNI) Shares Offered | 1,908,800 (26.49%) |
| Retail Shares Offered | 3,651,200 (50.67%) |
| Total Shares Offered | 7,206,400 (100%) |
Sudarshan Pharma Industries IPO Anchor Investors Details #
Sudarshan Pharma Industries IPO Anchor Investors list
| Bid Date | Mar 8, 2023 |
| Shares Offered | 780,800 |
| Anchor Portion Size (In Cr.) | 5.70 |
| Anchor lock-in period end date for 50% shares (30 Days) | May 5, 2023 |
| Anchor lock-in period end date for remaining shares (90 Days) | Jul 31, 2023 |
Sudarshan Pharma Industries IPO Timetable (Tentative) #
Sudarshan Pharma Industries IPO opens on Mar 9, 2023, and closes on Mar 14, 2023.
| Event | Tentative Date |
|---|---|
| Opening Date | Thursday, 9 March 2023 |
| Closing Date | Tuesday, 14 March 2023 |
| Basis of Allotment | Friday, 17 March 2023 |
| Initiation of Refunds | Monday, 20 March 2023 |
| Credit of Shares to Demat | Tuesday, 21 March 2023 |
| Listing Date | Wednesday, 22 March 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Mar 14, 2023 |
Sudarshan Pharma Industries IPO Lot Size #
The Sudarshan Pharma Industries IPO lot size is 1600 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹116,800 |
| Retail (Max) | 1 | 1600 | ₹116,800 |
| HNI (Min) | 2 | 3,200 | ₹233,600 |
| Lot Size Calculator | |||
Sudarshan Pharma Industries IPO Promoter Holding #
Mr. Hemal Vasantrai Mehta and Mr. Sachin Vasantrai Mehta are the Promoters of the company.
| Pre Issue Share Holding | 80.28% |
| Post Issue Share Holding |
Company Financials #
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31-Mar-21 | 9,926.02 | 19,372.82 | 267.12 | 2,250.74 | 1,296.05 | 2,977.09 |
| 31-Mar-22 | 13,752.18 | 35,755.89 | 530.37 | 2,977.53 | 2,002.63 | 3,059.24 |
| 30-Sep-22 | 16,402.22 | 19,589.87 | 360.70 | 5,108.79 | 3,996.89 | 4,940.50 |
| Amount in ₹ Lakhs | ||||||
Key Performance Indicator #
| KPI | Values |
|---|---|
| P/E (x) | 24.33 |
| Market Cap (₹ Cr.) | 175.68 |
Objects of the Issue #
The Company intends to utilize the Net Fresh Issue Proceeds for the following Objects:
- Working Capital Requirements
- General Corporate Purposes.
Sudarshan Pharma Industries IPO Subscription Status (Bidding Detail) #
The Sudarshan Pharma Industries IPO is subscribed 1.06 times on Mar 14, 2023 7:02:00 PM. The public issue subscribed 1.20 times in the retail category, 1.01 times in the QIB category, and 0.81 times in the NII category.
| Category | Subscription (times) |
|---|---|
| QIB | 1.01 |
| NII | 0.81 |
| Retail | 1.20 |
| Total | 1.06 |
Total Application : 3,005 (1.32 times)
Sudarshan Pharma Industries IPO Prospectus #
- › Sudarshan Pharma Industries IPO DRHP
- › Sudarshan Pharma Industries IPO RHP
- › Anchor Investors in Sudarshan Pharma Industries IPO
Sudarshan Pharma Industries IPO Listing Details #
| Listing Date | Mar 22, 2023 |
| BSE Script Code | 543828 |
| NSE Symbol | |
| ISIN | INE00TV01015 |
| Final Issue Price | ₹73 per share |
Listing Day Trading Information #
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE SME |
|---|
| ₹73.00 |
| ₹73.00 |
| ₹69.35 |
| ₹73.25 |
| ₹69.35 |
Company Contact Information #
301,3rd Floor, Aura Biplex,
Above Kalyan Jewellers S. V. Road, Borivali (West)
Mumbai – 400092
Phone: 022- 42221111
Email: compliance@sudarshanpharma.com
Website: http://www.sudarshanpharma.com/
Sudarshan Pharma Industries IPO Registrar #
Phone: 04067162222, 04079611000
Email: einward.ris@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Sudarshan Pharma Industries IPO Lead Manager(s) #
Frequently Asked Questions #
When does the Sudarshan Pharma Industries IPO open and close? #
The Sudarshan Pharma Industries IPO opens on March 9, 2023, and closes on March 14, 2023.
What is the IPO price and face value of Sudarshan Pharma Industries? #
The IPO price of Sudarshan Pharma Industries is ₹71 to ₹73 per equity share, and the face value is ₹10 per share.
What is the IPO size and lot size of Sudarshan Pharma Industries IPO? #
The Sudarshan Pharma Industries IPO size is ₹50.10 Crores, and the lot size is 1600 shares.
Where will Sudarshan Pharma Industries IPO be listed? #
Sudarshan Pharma Industries IPO will be listed on BSE SME on March 22, 2023.
What is the subscription status of Sudarshan Pharma Industries IPO? #
As of the latest update, the IPO has been subscribed 1.06 times, with Qualified Institutional Buyers (QIB) subscribing 1.01 times, Non-Institutional Investors (NII) subscribing 0.81 times, and Retail Individual Investors (RII) subscribing 1.20 times.
What are the objectives of the Sudarshan Pharma Industries IPO? #
The net proceeds from the IPO will be utilized for setting up a dedicated manufacturing facility for the pharmaceutical business, distribution and warehousing centers, additional working capital, general corporate expenses, and to meet the expenses.
How can I apply for Sudarshan Pharma Industries IPO? #
Retail investors can apply for Sudarshan Pharma Industries IPO shares online through the banks (using ASBA) or through the broker (using UPI). Several banks and brokers offer the facility for online IPO applications.
How can I check the Sudarshan Pharma Industries IPO subscription status?
You can check the live subscription status of Sudarshan Pharma Industries IPO on the official website or financial portals that provide such information.
What are the competitive strengths of Sudarshan Pharma Industries? #
The competitive strengths of Sudarshan Pharma Industries include its customer-centric and order-driven business model, a wide range of product offerings, contract manufacturing facility arrangements, strong distribution, marketing, and sales network, and diversified business operations.
Who are the promoters of Sudarshan Pharma Industries? #
The promoters of Sudarshan Pharma Industries are Mr. Hemal Vasantrai Mehta and Mr. Sachin V. Mehta.
Please note that the information provided here is based on the available data and may be subject to change. For the most up-to-date and accurate information, it is recommended to visit the official sources and financial portals directly.
